top of page

Darryl Hudson

Dr. Darryl Hudson is the co-founder and Chief Innovation Officer of GoodCap Pharmaceuticals where they are developing his novel, synergistic formulation of Psilocybin and Eugenol. Darryl has deep expertise in molecular biology, neuroscience, and genetics in psychedelics. He holds a PhD in molecular biology and genetics. Prior to founding GoodCap, Darryl co-founded InPlanta Biotechnology Inc. and Pathways Rx, where he led the development and commercialization of proprietary plant genetics. He has also co-authored numerous peer-reviewed research articles on plant biology, genetics, DNA repair, epigenetics, and cancer.

bottom of page